653 related articles for article (PubMed ID: 16642532)
1. Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties.
Li CK; Sun RW; Kui SC; Zhu N; Che CM
Chemistry; 2006 Jul; 12(20):5253-66. PubMed ID: 16642532
[TBL] [Abstract][Full Text] [Related]
2. Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.
Sun RW; Li CK; Ma DL; Yan JJ; Lok CN; Leung CH; Zhu N; Che CM
Chemistry; 2010 Mar; 16(10):3097-113. PubMed ID: 20162647
[TBL] [Abstract][Full Text] [Related]
3. New Variations on the Theme of Gold(III) C
Carboni S; Zucca A; Stoccoro S; Maiore L; Arca M; Ortu F; Artner C; Keppler BK; Meier-Menches SM; Casini A; Cinellu MA
Inorg Chem; 2018 Dec; 57(23):14852-14865. PubMed ID: 30457328
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of Pyrazine-Based Cyclometalated (C^N
Bertrand B; Fernandez-Cestau J; Angulo J; Cominetti MMD; Waller ZAE; Searcey M; O'Connell MA; Bochmann M
Inorg Chem; 2017 May; 56(10):5728-5740. PubMed ID: 28441013
[TBL] [Abstract][Full Text] [Related]
5. Exploring the C^N^C theme: Synthesis and biological properties of tridentate cyclometalated gold(III) complexes.
Jürgens S; Scalcon V; Estrada-Ortiz N; Folda A; Tonolo F; Jandl C; Browne DL; Rigobello MP; Kühn FE; Casini A
Bioorg Med Chem; 2017 Oct; 25(20):5452-5460. PubMed ID: 28823538
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterisation and biological properties of gold(III) compounds with modified bipyridine and bipyridylamine ligands.
Casini A; Diawara MC; Scopelliti R; Zakeeruddin SM; Grätzel M; Dyson PJ
Dalton Trans; 2010 Mar; 39(9):2239-45. PubMed ID: 20162197
[TBL] [Abstract][Full Text] [Related]
7. Gold(III) complexes with bipyridyl ligands: solution chemistry, cytotoxicity, and DNA binding properties.
Marcon G; Carotti S; Coronnello M; Messori L; Mini E; Orioli P; Mazzei T; Cinellu MA; Minghetti G
J Med Chem; 2002 Apr; 45(8):1672-7. PubMed ID: 11931621
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of the antitumoral activity of phosphine-thiosemicarbazone gold(I) complexes obtained by different methodologies.
González-Barcia LM; Fernández-Fariña S; Rodríguez-Silva L; Bermejo MR; González-Noya AM; Pedrido R
J Inorg Biochem; 2020 Feb; 203():110931. PubMed ID: 31786438
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships in cytotoxic Au(I)/Au(III) complexes derived from 2-(2'-pyridyl)benzimidazole.
Maiore L; Aragoni MC; Deiana C; Cinellu MA; Isaia F; Lippolis V; Pintus A; Serratrice M; Arca M
Inorg Chem; 2014 Apr; 53(8):4068-80. PubMed ID: 24679072
[TBL] [Abstract][Full Text] [Related]
10. Chemical behavior and in vitro activity of mixed phosphine gold(I) compounds on melanoma cell lines.
Caruso F; Pettinari C; Paduano F; Villa R; Marchetti F; Monti E; Rossi M
J Med Chem; 2008 Mar; 51(6):1584-91. PubMed ID: 18307291
[TBL] [Abstract][Full Text] [Related]
11. Structural and solution chemistry, antiproliferative effects, and DNA and protein binding properties of a series of dinuclear gold(III) compounds with bipyridyl ligands.
Casini A; Cinellu MA; Minghetti G; Gabbiani C; Coronnello M; Mini E; Messori L
J Med Chem; 2006 Sep; 49(18):5524-31. PubMed ID: 16942025
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of apoptosis-inducing iminophosphorane organogold(III) complexes and study of their interactions with biomolecular targets.
Shaik N; Martínez A; Augustin I; Giovinazzo H; Varela-Ramírez A; Sanaú M; Aguilera RJ; Contel M
Inorg Chem; 2009 Feb; 48(4):1577-87. PubMed ID: 19146434
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, properties, and antitumor effects of a new mixed phosphine gold(I) compound in human colon cancer cells.
Lupidi G; Avenali L; Bramucci M; Quassinti L; Pettinari R; Khalife HK; Gali-Muhtasib H; Marchetti F; Pettinari C
J Inorg Biochem; 2013 Jul; 124():78-87. PubMed ID: 23632460
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic studies on two dinuclear organogold(III) compounds showing appreciable antiproliferative properties and a high redox stability.
Gabbiani C; Casini A; Kelter G; Cocco F; Cinellu MA; Fiebig HH; Messori L
Metallomics; 2011 Dec; 3(12):1318-23. PubMed ID: 21887452
[TBL] [Abstract][Full Text] [Related]
15. Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand.
Maiore L; Cinellu MA; Michelucci E; Moneti G; Nobili S; Landini I; Mini E; Guerri A; Gabbiani C; Messori L
J Inorg Biochem; 2011 Mar; 105(3):348-55. PubMed ID: 21421122
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of gold(I) phosphine complexes containing the 2-BrC
Reddy TS; Privér SH; Mirzadeh N; Bhargava SK
Eur J Med Chem; 2018 Feb; 145():291-301. PubMed ID: 29331752
[TBL] [Abstract][Full Text] [Related]
17. Gold complexes with the selenolate ligand [2-(Me2NCH2)C6H4Se]-.
Crespo O; Gimeno MC; Laguna A; Kulcsar M; Silvestru C
Inorg Chem; 2009 May; 48(9):4134-42. PubMed ID: 19326899
[TBL] [Abstract][Full Text] [Related]
18. In Vitro Antitumor Active Gold(I) Triphenylphosphane Complexes Containing 7-Azaindoles.
Štarha P; Trávníček Z; Drahoš B; Dvořák Z
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27973440
[TBL] [Abstract][Full Text] [Related]
19. The synthesis, chemical and biological properties of dichlorido(azpy)gold(III) chloride (azpy=2-(phenylazo)pyridine) and the gold-induced conversion of the azpy ligand to the chloride of the novel tricyclic pyrido[2,1-c][1,2,4]benzotriazin-11-ium cation.
Garza-Ortiz A; den Dulk H; Brouwer J; Kooijman H; Spek AL; Reedijk J
J Inorg Biochem; 2007 Nov; 101(11-12):1922-30. PubMed ID: 17637477
[TBL] [Abstract][Full Text] [Related]
20. Acridine-decorated cyclometallated gold(iii) complexes: synthesis and anti-tumour investigations.
Williams MRM; Bertrand B; Fernandez-Cestau J; Waller ZAE; O'Connell MA; Searcey M; Bochmann M
Dalton Trans; 2018 Oct; 47(38):13523-13534. PubMed ID: 30204186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
